About Hospira News & Media Investor RelationsIn the Community
Annual Reports/
Proxies
Quarterly Reports/
Supplemental Tables
2010 Proxy Materials
SEC Filings
Insider Transactions
Tax Information for Shareholders
Stock Quote
Stock Chart
Shareholder FAQ
Analyst Coverage
Press Releases
Presentations
IR Calendar
Email Alerts  
Hospira Leadership
Board of Directors
Board Committees
and Charters
Corporate Governance
Guidelines
Share Ownership Guidelines
Long Term
Incentives Policy
Hospira Code of Business Conduct

Board of Directors
Christopher B. BegleyChairman of the Board and Chief Executive Officer, Hospira, Inc.
Irving W. Bailey IILead Director
Barbara L. Bowles, CFADirector
Connie R. Curran, R.N., Ed. DDirector
Roger W. HaleDirector
Jacque J. Sokolov, M.D.Director
John C. StaleyDirector
Heino von ProndzynskiDirector
Mark F. Wheeler, M.D., M.P.H.Director

You may communicate with our directors or our independent directors as a group by writing a letter to the chairman of our audit committee (for accounting, internal controls or auditing matters), the lead director or any of our other independent directors. Please address your correspondence to:

Director Communications
c/o: Hospira General Counsel and Secretary
Hospira, Inc.
275 North Field Drive
Lake Forest, Illinois 60045

Our general counsel and secretary will review the communication and forward the communication to the addressee, or in the absence of an addressee, to the director or directors he believes to be most appropriate.

In addition, you may report concerns relating to accounting, internal controls or auditing matters on anonymous basis by calling the Helpline of our Office of Ethics and Compliance by calling 1.866.311.4632. These matters will be investigated and referred to the audit committee of out board of directors.